Optimizing rapid diagnostics and diagnostic stewardship in Gram-negative bacteremia

Area of Science:

• Clinical microbiology
• Infectious diseases
• Healthcare management

Background:

• Antimicrobial resistance (AMR) poses a significant global health threat, leading to increased hospital stays, severe illness, higher death rates, and rising healthcare expenses.
• Rapid diagnostic technology (RDT) is crucial for timely blood culture analysis, enabling prompt treatment initiation, reducing mortality, and curbing the spread of resistance.
• Effective management of RDTs requires integration into antimicrobial stewardship programs (ASPs).

Purpose of the Study:

• To highlight the importance of diagnostic stewardship (DS) within antimicrobial stewardship programs (ASPs).
• To emphasize the role of DS in optimizing the use of rapid diagnostic technologies (RDTs).
• To underscore the necessity of DS for improving patient outcomes in the context of antimicrobial resistance.

Main Methods:

• This study emphasizes the strategic implementation of a diagnostic stewardship (DS) subgroup.
• The DS subgroup focuses on enhancing communication, education, and interpretation of RDT results.
• Evaluation of available RDTs and their integration into healthcare systems are key components.

Main Results:

• Diagnostic stewardship (DS) is essential for maximizing the benefits of rapid diagnostic technology (RDT).
• DS facilitates better integration and appropriate use of RDTs within healthcare settings.
• Optimized RDT utilization through DS leads to improved patient outcomes and combats antimicrobial resistance.

Conclusions:

• Antimicrobial resistance necessitates strategic approaches like diagnostic stewardship.
• Diagnostic stewardship subgroups are vital for effective implementation and utilization of RDTs.
• Integrating DS into ASPs is crucial for improving patient care and controlling antimicrobial resistance.